Search

Your search keyword '"Skoda, Radek"' showing total 796 results

Search Constraints

Start Over You searched for: Author "Skoda, Radek" Remove constraint Author: "Skoda, Radek"
796 results on '"Skoda, Radek"'

Search Results

2. Nuclear and cytosolic fractions of SOX2 synergize as transcriptional and translational co-regulators of cell fate

6. Proteogenetic drug response profiling elucidates targetable vulnerabilities of myelofibrosis

13. Iron is a modifier of the phenotypes of JAK2-mutant myeloproliferative neoplasms

18. Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs

23. Loss of Dnmt3a increased self-renewal and resistance to pegIFNα in JAK2-V617F-positive myeloproliferative neoplasms

24. NLRP3-induced systemic inflammation controls the development of JAK2V617F mutant myeloproliferative neoplasms

30. Perovskites as Potential Candidates for Storage and Conversion of Spent Nuclear Fuel Energy

32. JAK2-mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms

38. Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms

39. Ruxolitinib-induced defects in DNA repair cause sensitivity to PARP inhibitors in myeloproliferative neoplasms

44. IL-1β promotes MPN disease initiation by favoring early clonal expansion ofJAK2-mutant hematopoietic stem cells

46. Table S3 from Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation

47. Supplementary Figures and Legends from Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation

48. Data from Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation

50. Proteogenetic drug response profiling elucidates targetable vulnerabilities of myelofibrosis

Catalog

Books, media, physical & digital resources